AqueSys is an ophthalmic company, which focuses on innovating and commercializing implantable devices for treatment of glaucoma. It offers XEN, a gel stent that creates a diffuse outflow of aqueous from the anterior chamber into the non-dissected tissue of the subconjunctival space. The Company’s XEN gel stent creates a new pathway to allow the excess fluid in eyes to flow out, and lowers eye pressure.